Auste Kanapeckaite


Auste has been working across various academic, commercial and R&D roles for more than 10 years now where she headed drug and therapeutics development projects with a focus on rare, immune and metabolic diseases. Auste is currently responsible for the scientific vision of an in silico therapeutics company, Algorithm379, and advocates for using bioinformatics, computational biology as well as cheminformatics to find better healthcare solutions for those in need.